BioCentury
ARTICLE | Finance

From pore to rich

How Oxford Nanopore regained the U.K.'s top private money raised spot

July 27, 2015 7:00 AM UTC

Oxford Nanopore Technologies Ltd. has chosen investors that look more like a public company's - and now the nanopore-based sequencing company has a valuation to match.

Oxford Nanopore raised £70 million ($109.2 million) last week with new and existing investors in the U.K., U.S. and continental Europe. The financing brings the company's total money raised to £251 million ($391.6 million), making Oxford one of only two U.K. biotechs to have raised more than $200 million as private companies...